Latest Innovation News

Green360 Technologies has successfully raised A$4 million through a share placement to fund the commercialisation and scaling of its innovative low-carbon cement technology, supported by institutional investors and strengthened leadership.

DigitalX Limited has announced a bold strategy to increase its Bitcoin holdings more than fourfold by the end of 2027, reinforcing its position as a leading Australian digital asset manager.

RocketBoots Limited has secured a significant trial contract with a major Australian retail bank, potentially expanding to a $234k SaaS rollout that could boost its recurring revenue and international ambitions.

Provaris Energy has launched a fully funded Front End Engineering Design phase for its proprietary large-scale liquid CO2 tanks, backed by Yinson. The move signals growing market interest in scalable carbon capture shipping solutions, especially across Asia.

DroneShield launches SentryCiv, a subscription-based AI-powered counter-drone solution designed to protect civilian critical infrastructure from emerging aerial threats.

Iress Limited reported a robust first half of 2025 with strong earnings growth and reduced leverage, driven by core business strength and strategic divestments. The company is poised to capitalize on regulatory tailwinds and technology demand in wealth and trading sectors.

Iress Limited has reported a 19% increase in underlying earnings per share for its continuing business in the first half of 2025, completing a major transformation and reaffirming its full-year guidance despite revenue pressures from divestments.

AnteoTech Ltd has received a $2.59 million cash rebate from the Australian Tax Office for its 2025 R&D activities, underscoring the success of its recent strategic initiatives.

JB Hi-Fi reported a robust FY25 with 10% sales growth and increased dividends, while preparing for a leadership change.

Iress Limited reported a stable half-year profit for 2025, maintaining net earnings despite a slight revenue dip and ongoing divestments. The company strengthened its balance sheet through debt reduction and declared a healthy interim dividend, while exploring potential acquisition opportunities.

Noxopharm Limited has successfully completed the second dose cohort in its HERACLES Phase 1 trial for SOF-SKN™, confirming safety and tolerability and moving forward to a higher dose. This progress marks a key step in developing a novel autoimmune disease treatment.

JB Hi-Fi announces a seamless leadership transition with Nick Wells set to succeed Terry Smart as Group CEO in October 2025, underscoring strong succession planning and continuity.